Renalytix AI (GB:RENX) has released an update.
Renalytix AI has submitted a hearing request to the Nasdaq Hearings Panel to address its delisting due to non-compliance with market value and minimum bid price requirements. The company’s American Depositary Shares will continue trading on The Nasdaq Global Market under the symbol ‘RNLX’ until the Panel’s decision is made. Renalytix AI’s plan to regain compliance will be presented at the hearing, but there is no guarantee of its acceptance or the company’s ability to meet Nasdaq’s listing criteria moving forward.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.
